Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of sorafenib + dacarbazine in metastatic melanoma
2005-005138-11Phase 2Active
- Sponsor
- Dr. JOSE LUIS GONZALEZ LARRIBA
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sorafenib and dacarbazine in melanoma, sponsored by Dr. JOSE LUIS GONZALEZ LARRIBA. Primary endpoint: Disease control rate. Started Feb 2006; status: active.
02
Drugs
sorafenibdacarbazine
03
Conditions
melanoma
Beyond the preview
Go deeper on 2005-005138-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005138-11.